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Background: Interstitial pneumonias (IP) cover a broad spectrum of diseases. Open lung biopsies reveal histological
patterns and suggest possible diagnoses. Complete clinical records are necessary for final diagnoses. Especially
idiopathic interstitial pneumonias (IIP) according to the ATS/ERS classification can only be diagnosed under these
predictions. The aim of this study was to compare the results of histological evaluations with the final diagnosis
after interdisciplinary case evaluation.
Patients and methods: 88 patients with interstitial pneumonia that underwent open lung biopsies were
investigated. Histology and clinical records were available for review. Diagnosis was made in three steps: first on the
sole basis of histology, second with clinical information given initially and third, on the basis of an interdisciplinary
case evaluation.
Results: 63 patients (72%) were diagnosed as idiopathic interstitial pneumonias according to ATS/ERS criteria.
Further 10 (11%) cases of hypersensitivity pneumonitis, 7 (8%) Langerhans cell histiocytosis and 8 (9%) interstitial
pneumonias of other known causes or associations were detected. Histological patterns alone agreed with the final
diagnosis in 67%. In 82% histology and clinical information given to the pathologist could provide correct
diagnosis. In the rest of cases, especially in non idiopathic interstitial pneumonias, an interdisciplinary case
evaluation was needed.
Conclusions: Diagnosis of interstitial pneumonias by open lung biopsies needs sufficient clinical information.
Because of the overlap of histological patterns, an interdisciplinary case evaluation that includes at least one clinical
expert and one pathologist with excellent expertise and the follow-up of the patients is necessary to find correct
diagnosis in all cases.
Virtual slides: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
5031706258025129Background
Diffuse interstitial lung diseases (ILD) are disorders with
a large spectrum of possible underlying causes. Most of
ILD belong to the group of idiopathic interstitial pneu-
monias (IIP). But these diagnoses can only be made after
exclusion of known etiological factors or associations.
Pulmonary fibrosis was first described by VON BÜHL
in 1872 [1]. The first generally accepted classification
of idiopathic interstitial pneumonia was introduced by
LIEBOW in 1975 [2]. He distinguished usual interstitial
pneumonia (UIP), bronchiolitis obliterans with interstitial* Correspondence: dirk.theegarten@uk-essen.de
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distribution, and reproduction in any mediumpneumonia (BIP), desquamative interstitial pneumonia
(DIP), lymphocytic interstitial pneumonia (LIP) and inter-
stitial giant cell pneumonia (GIP). In 1990, KITAICHI
described a further group designated as “unclassified inter-
stitial pneumonia” [3]. This led to a revision of the Liebow
classification by A. KATZENSTEIN [4]. The categories
UIP and DIP remained, but LIP and GIP were abandoned,
because they were no longer regarded as idiopathic
disease. Respiratory bronchiolitis with interstitial lung dis-
ease (RBILD), acute interstitial pneumonia (AIP) and the
non specific interstitial pneumonia (NSIP) were intro-
duced as new entities.
The ATS/ERS (American Thoracic Society/European
Respiratory Society) international multidisciplinary con-
sensus classification of idiopathic interstitial pneumoniastral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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gists and radiologists in order to standardize classifica-
tion and achieve a broad acceptance among the
participating disciplines [5]. By this classification LIP
was reintroduced, but non idiopathic cases have to be
excluded faithfully [6]. In clinical practise overlap to fol-
licular bronchiolitis has been found [7].
Revised evidence-based guidelines for diagnosis and
management of IPF as a collaborative effort between the
ATS, ERS, Japanese Respiratory Society (JRS), and Latin
American Thoracic Association (ALAT) have been pub-
lished in 2011 [8]. Non idiopathic origin of IIP has to be
evaluated carefully, pulmonary symptoms can even
proceed manifestations of connective tissue diseases [9].
Interobserver variability in the diagnosis of ILD is a
problem for chest physicians, radiologists and patholo-
gists [10-13]. Discordances also exist between general
and pulmonary pathologists in the diagnosis of intersti-
tial lung disease [14]. Therefore, standardization of the
diagnostic process and quality assessment are necessary.
The aim of this study was the evaluation of patients
with IIP undergoing open lung biopsies in three diagnos-
tic steps to investigate the benefit of clinical information
and final interdisciplinary case evaluation.
Patients and methods
Selection and categorization of the patients
All cases with histological diagnosis of interstitial pneu-
monia or pulmonary fibrosis involving patients of the
Ruhrlandklinik Essen – West German Lung Center at
the University Hospital Essen between 1993 and 2000
were retrospectively selected from the archive of the
Department of Pathology at the Ruhr-University Bo-
chum. The indication to perform open lung biopsies had
been made by the clinicians on the basis of the available
guidelines at that time. All patients have given written
consent to surgical procedures und scientific evaluation
of data. Data protection was done according to legal
foundations. Patients without open lung biopsy (OLB)
were excluded. Clinical records were reviewed in each
case, follow up was requested by contacting local practi-
tioners. Digital images or photographs of thoracic im-
aging (CXR, CT and HRCT) were only partially available
for diagnostic review and written descriptions of radio-
logical findings were often of poor quality. Therefore
results of thoracic imaging were not included in the
evaluation process.
Bronchoalveolar lavage
BAL was performed during local anesthesia using fiber-
optic bronchoscopy according to established guidelines
[15]. In brief, a flexible bronchoscope was wedged into a
segmental bronchus of the middle lobe or the lingula.
Sterile isotonic saline was instilled in five to ten 20 mlaliquots up to a total volume of 100–200 ml, with imme-
diate aspiration by gentle suction after each aliquot. The
recovered BAL fluid was immediately processed in the
laboratory. The fluid was pooled, filtered through two
layers of gauze, and centrifuged at 500 g for 10 min at
room temperature. The cells were counted in a haemo-
cytometer. Slides were stained with May-Grünwald-
Giemsa stain (Merck, Germany) and a total of 600 cells
were counted for the cell differentials. A trypan blue ex-
clusion test was performed for evaluating cell viability.Histology and immunohistochemistry
Slides were stained with hematoxylin and eosin in all
cases, further slides with Elastica van Gieson, Periodic
Acid Schiff and Prussian Blue stains were available in
parts. In cases of suspected Langerhans cell histio-
cytosis immunohistochemistry with monoclonal anti-
bodies against S-100 Protein and CD1a was done (ABC
method, DAKO Hamburg, Germany). Additionally in
one case of LIP staining for lymphocyte subtypes (CD 3
and CD 20, ABC method, DAKO Hamburg, Germany)
was performed.Diagnostic evaluation process
Diagnostic evaluation was done in three steps. Firstly,
diagnosis was made as a slide review on the basis of
histological patterns found by the pathologist (DT),
blinded to the BAL results and other clinical data. Confi-
dence of histological diagnosis was estimated as certain,
probable or possible. If no clear cut diagnosis could be
made, the most probable diagnosis was listed. Secondly,
histological re-evaluation was done on the basis of clin-
ical diagnoses made by the clinician given on the path-
ology request form. Thirdly, final diagnosis was made by
the pulmonologist (UC) and the pathologist (DT) on the
light of all clinical, radiological and histological data as
interdisciplinary case evaluation (Figure 1). The results
of these three diagnostic steps were compared.Statistics
Data are expressed as mean ± standard deviation. We
used t-student test and ANOVA, for two or multiple
groups respectively, to compare normally distributed
variables. Comparison of non-normally distributed vari-
ables between two groups was done with the Mann–
Whitney U test. Comparison of categorical variables be-
tween two groups, including the results of the single
diagnostic steps vs interdisciplinary case evaluation, was
done by the Fisher’s exact probability test. All statistical
analyses were done using SPSS version 17.0 for Win-
dows (SPSS Inc., Chicago, IL). Differences were consid-
ered statistically significant when the p value was < 0.05.
Figure 1 Diagnostic steps in interstitial lung diseases. Different steps necessary for sufficient diagnosis.
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A total of 92 cases with interstitial pneumonia under-
went diagnostical evaluation. 3 patients with putride
pneumonia and one patient with bronchiolitis were
excluded from further analysis. Overall confidence of
histological evaluation was estimated as certain in 67%
of cases (N = 62), probable in 24% of cases (N = 22), and
possible in 9% (N = 8). Histological patterns alone agreed
with the final diagnosis in 67% of cases and in 82%Table 1 Diagnosis of the different IP subtypes in 3 steps
Interstitial lung diseases (n = 88) Step 1: histology
alone (pattern)
Idiopathic interstitial pneumonia or pattern* 85
IPF/Usual interstitial pneumonia (UIP) 31
Non specific interstitial pneumonia (NSIP) 21
Respiratory bronchiolitis with ILD (RBILD) 14
Desquamative interstitial pneumonia (DIP) 3
Cryptogenic organizing pneumonia (COP) 13
Acute interstitial pneumonia (AIP) 1
Lymphocytic interstitial pneumonia (LIP) 3
Non idiopathic interstitial pneumonia 3
Hypersensitivity pneumonitis (HP) 0
Langerhans cell histiocytosis (LCH) 3
IP of other known causes or associations 0
Correctness of diagnosis (total) 67%*
*p < 0.05 vs interdisciplinary case evaluation (exact Fisher test).histology and clinical information provided the diagno-
sis, compared with interdisciplinary case evaluation
(Table 1, p < 0.037 exact Fisher’s test).
Idiopathic interstitial pneumonia (IIP)
63 patients (72%) were diagnosed as idiopathic intersti-
tial pneumonias by interdisciplinary case evaluation
according to ATS/ERS criteria (Table 1). There were 27
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(NSIP), 6 (9.5%) with respiratory bronchiolitis with inter-
stitial lung disease (RBILD), 3 (5%) with desquamative
interstitial pneumonia (DIP), 10 (16%) with cryptogenic
organizing pneumonia (COP) and 3 (5%) with lympho-
cytic interstitial pneumonia (LIP).
Usual interstitial pneumonia (UIP)/Idiopathic pulmonary
fibrosis (IPF)
Male patients were dominant (Table 2). The patients’
mean age was 60 years, the oldest among all ILDs. Clin-
ically, dyspnea (96%) and cough (78%) were present.
There were 67% smokers with a mean of 17.2 pack years
(Table 2). Bronchoalveolar lavage (BAL) showed a lower
percentage of lymphocytes (18%) than NSIP, COP, or HP
cases (Table 3).
Microscopically a UIP pattern with heterogene changes,
honeycombing, a variable fibrosis, mucus plugging, lym-
phoplasmacytic infiltrates of variable densities and fibro-
blastic foci was seen (Figure 2).
Non specific interstitial pneumonia (NSIP)
In this group, most patients were female (Table 2). The
mean age was 49.2 years and dyspnea (93%) and cough
(64%) were found present since 1.7 years (Table 2).Table 2 Demographics and patients’ characteristics according
All IPF/UIP NS
Patients (N) 74 27 1
Gender,male/female 43/31 21/6 6/
Age, mean ± SE 53 ± 11 60 ± 11 51 ±
BMI, kg/m2 26 ± 5 28 ± 5 26
Smoking history
- current/ex (%) 47 (64) 18 (67) 8 (5
- never smokers 27 (36) 9 (33) 6 (4
Pack years, mean 20.4 17 14
Symptoms
- dyspnoea (%) 65 (88) 26 (96) 13 (
- cough (%) 54 (73) 22 (78) 9 (6
Duration of symptoms, years 2.2 1.6 1.7
FVC % pred, mean ± SE 66 ± 15 61 ± 16 61
FEV1, % pred, mean ± SE 66 ± 14 66 ± 15 65 ±
TLC, % pred, mean ± SE 78 ± 20 67 ± 14 77 ±
PaO2, mmHg 74 ± 10 73 ± 8 73
PaCO2, mmHg 38 ± 4 39 ± 4 36
AaDO2, mmHg 28 ± 16 33 ± 19 30 ±
n.a. = not available.
* p <0.005 vs IPF/UIP.
** p < 0.05 vs IPF/UIP.
† p < 0.05 vs RBILD and COP.
†† p < 0.05 vs HP and LCH.Moreover, 50% of the patients were suffering from clear
expectorations and chronic fatigue (data not shown).
There were 57% smokers with a mean of 14.5 pack years.
Bronchoalveolar lavage showed a mild lymphocytosis
(36%) (Table 3).
Histologically, interstitial pneumonia without any diag-
nostic criteria of other pulmonary diseases was found.
The alterations consisted primarily of a mild to moder-
ate interstitial chronic inflammation, usually with lym-
phocytes and a few plasma cells. A mesh-like or
bronchiolocentric fibrosis sometimes also with honey-
combing, but without fibroblastic foci was demonstrated
(Figure 3). All cases showed fibrotic changes, however, a
prominent inflammation (cellular pattern) could not be
noted. NSIP patterns were also found in cases of EAA
and interstitial pneumonias of other known causes and
associations (Table 1).Respiratory bronchiolitis with interstitial lung disease
(RBILD)
Male gender was dominant, in this group (Table 2). Be-
side dyspnea and cough, expectoration and fatigue were
also present (both in 67% of patients). All patients were
smokers with a mean of 27 pack years (Table 2).to diagnosis by interdisciplinary evaluation
IP RBILD COP HP LCH
4 6 10 10 7
8 5/1* 7/3 2/8** 2/5
14* 44 ± 6* 58 ± 11 52 ± 10 44 ± 12*
± 4 26 ± 4 26 ± 4 24 ± 3 24 ± 8**
7) 6 (100)* 7 (70) 1 (10) 7 (100)*
3) 0 (0) 3 (30) 9 (90) 0 (0)
.5 27 21 n.a. 22.5
93) 4 (67) 7 (70) 10 (100) 5 (71)
4) 3 (50) 8 (80) 8 (80) 4 (57)
†† 1.4 0.3†† 4.3** 4.2**
± 9 71 ± 7 72 ± 11 57 ± 13 78 ± 19**
12 77 ± 12 77 ± 13 63 ± 14 54 ± 21†
15 91 ± 15* 85 ± 19* 68 ± 10 98 ± 17*
± 8 80 ± 8 70 ± 14 78 ± 10 72 ± 13
± 3 39 ± 3 40 ± 5 39 ± 3 37 ± 4
11 13 ± 6** 25 ± 12 22 ± 10 16 ± 7
Table 3 BAL findings according to final interdisciplinary diagnosis
BAL counts (%) Normal range UIP/IPF NSIP RBILD COP HP LCH
macrophages >84 64 ± 20 45.3 ± 31 77 ± 21* 46 ± 33 33 ± 18** 86 ± 17
lymphocytes <13 18 ± 13 36 ± 27 14 ± 9 40 ± 33† 60 ± 18†† 4.5 ± 3
neutrophiles <3 10 ± 6 13.3 ± 11 6.8 ± 6.2 8 ±11 5.5 ± 5 7.5 ± 10
eosinophiles <0.5 7.5 ± 4.7 5 ± 6.5 2 ± 2 5.7 ± 4 1.3 ± 0,8 1.5 ± 2
mast cells <0.5 0.5 ± 0.4 0. ± 0.3 0.2 ± 0.2 0.3 ± 0.3 0.2 ± 0.3 0.5 ± 0.4
CD4/CD8 1.1-3.5 1.6 ± 1.5 2.1 ± 1.7 0.6 ± 0.1 2 ±0.9 3.7 ± 2.7 n.a.
n.a. = not available.
* p < 0.05 vs NSIP, COP and HP.
** p < 0.05 vs UIP/IPF.
† p < 0.05 vs UIP/IPF, HP und RBILD.
†† p < 0.05 vs UIP/IPF, NSIP, COP, RBILD, und LCH.
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phages (77%) (Table 3).
Morphologically a bronchiolocentric aggregation of
macrophages in combination with slight fibrosis and
some interstitial infiltrates were seen (Figure 4). Respira-
tory bronchiolitis was also found in EAA and LH, which
could be clarified after immunohistochemistry or case
evaluation (Table 1).Desquamative interstitial pneumonia (DIP)
Patients were mostly male (5/6), the mean age was
50.5 years (Table 2). Two patients were active smokers
with a mean consumption of 8 pack years. Bronchoalveo-
lar lavage showed an increase of neutrophils (34%) and
eosinophils (4%).
Biopsies revealed a massive intraalveolar aggregation
of macrophages. Besides a low grade interstitial fibrosis
without honeycombing, some lymphocytes were seen
(Figure 5). All cases were diagnosed already without clin-
ical data (Table 1).Figure 2 Usual interstitial pneumonia. The UIP pattern shows
honey combing and fibroblastic foci (haematoxylin eosin stain (HE),
original magnification 100x).Cryptogenic organizing pneumonia (COP)
Patients were mainly male and smokers, with a mean of
21.4 pack years (Table 2). Half of the patients had a his-
tory of pneumonia (data not shown). In the BAL fluid,
lymphocytosis was seen (40%) (Table 3).
Morphologically granulation tissue was found within
the bronchioles, alveolar ducts and the alveolar spaces,
which was accompanied by an interstitial inflammatory
reaction (Figure 6). Organizing pneumonia (OP) was
also seen in cases of NSIP and interstitial pneumonias of
other known causes and associations, which caused ini-
tial misdiagnoses before case evaluation (Table 1).
Lymphocytic interstitial pneumonia (LIP)
All patients (n = 3) were male and in the mean 55.9 years
old. There were no smokers among the patients (Table 2).
In BAL, lymphocytosis was seen (45.5%).
Microscopically, a dense lympho-plasmacellular infil-
tration with germinal centres but without blast prolifera-
tions were seen (Figure 7). There were no findingsFigure 3 Non specific interstitial pneumonia. A mesh-like fibrosis
of the alveolar septa is seen. Fibroblastic foci are not found.
Aggregates of lymphocytes are sometimes found (HE, original
magnification 40x).
Figure 4 Respiratory bronchiolitis with interstiatial lung
disease. In RBILD bronchiolocentric aggregates of macrophages and
an associated interstitial fibrosis are seen (HE, original magnification
40x).
Figure 6 Cryptogenic organizing pneumonia. In alveolar ducts
and bronchioles buds of granulation tissue are detected (HE, original
magnification 100x).
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of clinical or subclinical connective tissue diseases or
immunodeficiency was given in these patients. All cases
could already be diagnosed without any clinical informa-
tion (Table 1). Because of the small number of patients
enrolled, no statistical calculation could be performed.Non idiopathic interstitial pneumonia
25 patients (28%) had interstitial pneumonia of non
idiopathic origin. Among these were 10 cases of
hypersensitivity pneumonitis (11%), 7 of Langerhans cell
histiocytosis (8%), and 8 of interstitial pneumonias of
other known causes and associations (9%). Non idiopathic
interstitial pneumonias could not be diagnosed withoutFigure 5 Desquamative interstitial pneumonia. A pronounced
diffuse intraalveolar aggregation of macrophages and an interstitial
fibrosis can be found in DIP (HE. original magnification 40x).interdisciplinary case evaluation (first step: 12% vs. second
step: 44% correctness).
Hypersensitivity pneumonitis (HP)
There was a prevalence of females in this group (Table 2).
Dyspnea was seen in all patients; cough (80%) and
expectorations (70%) were also reported (Table 2). All
patients were positive for precipitins to several
different avian serum antigens (data not shown). In
the BAL 60% lymphocytes, 33% macrophages, 5.5%
neutrophils, 1.3% eosinophils and 0.2% mast cells
were seen (Table 3).
Cases were classified according to dominating pattern
as UIP (n = 2), RB (n = 2), NSIP (n = 5) and OP (n = 1).
In three cases histiocytic aggregates and granulomasFigure 7 Lymphocytic interstitial pneumonia. Prominent
infiltrates of lymphocytes and plasmacells and some germinal
centers are seen (HE, original magnification 40x).
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pathological diagnosis of HP (Figure 8, Table 1). Only
case specific evaluation allowed diagnosis in all patients.Figure 9 Langerhans cell histiocytosis. Patchy infiltrates ofLangerhans cell histiocytosis (LCH)
These patients were younger than those with IPF, NSIP,
and the other ILD (p < 0.05) and were 100% smokers,
with a mean consumption of 22.5 pack years. In the
BAL 4.5% lymphocytes, 86% macrophages, 7.5% neutro-
phils, 1.5% eosinophils and 0.5% mast cells were seen
(Table 3).
Initially without clinical information four cases were
diagnosed as RBILD (Table 1). Morphologically defini-
tive diagnosis could be made in all cases by immunohis-
tochemical demonstration of Langerhans cells (positive
reaction for CD1a and S100 protein, Figures 9, 10).histiocytes, lymphocytes and plasmacells are seen (HE, original
magnification 100x).Interstitial pneumonias of other known causes
and associations
There were 8 patients in this group, mostly male
(Table 2), their mean age was 55.4 years. Dyspnea was
present in all patients, and cough in 62.5% and fatigue in
62.5%. Most patients were smokers (62.5%, mean 13.1
pack years).
Morphologically OP (n = 3) and NSIP-like (n = 2),
UIP-like (n = 2) or DAD-like (n = 1) patterns were seen.
OP was found in IP with concomitant giant bullous em-
physema, colitis ulcerosa and alcoholic cirrhosis. NSIP-
like histology was seen in asbestosis and bone marrow
transplantation, UIP-like changes in Jo-1 syndrome and
after ACE inhibitor therapy. A DAD-like pattern was
found in a patient with rheumatoid arthritis (Table 4).
Asbestosis was diagnosed after detection of asbestos
body fragments in the tissue and of asbestos bodies inFigure 8 Hypersensitivity pneumonitis. Interstitial infiltrates of
lymphocytes and plasmacells and some aggregates of histiocytic
cells are found (HE, original magnification 100x).BAL. But all other cases were only detected after case
specific evaluation (Table 1).
Discussion
In general, the diagnostic criteria defined by the ATS/ERS
classification of IP were applicable in all cases. Distribu-
tions of subgroups of IIP in this study were in accordance
with the existing literature (Table 5). Some small
differences might be explained by selection of patients for
open lung biopsies. The number of LIP cases seems to be
higher than in other studies, where it is described as rare
disease with a frequency below 2% [16,17].
With regards to demographics and patients’ characteris-
tics, male predominance in IPF was also found in otherFigure 10 Immunohistochemistry of Langerhans cell
histiocytosis. Aggregates of Langerhans cells are detectable by
monoclonal antibodies against CD1a (ABC-method, original
magnification 200x).
Table 4 Patterns in interstitial pneumonias of other known causes and associations (n = 8)
Histological pattern Total Etiology
organizing pneumonia 3 Giant bullous emphysema* (1), Colitis ulcerosa (1), Liver cirrhosis (1)
UIP-like 2 Jo-1 syndrome (1), ACE-Inhibitors (1)
NSIP-like 2 Asbestosis (1), bone marrow transplantation (1)
DAD-like 1 Rheumatoid arthritis (1)
*in dominant ILD.
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as in COP [29-32]. Concerning NSIP, some studies found
a female predominance [33,34], while others noted a male
predominance [18,25,35]. In comparison to other studies
the clinical history, main clinical symptoms and the rate
of smokers in the different subgroups of IP showed only
small deviations (Table 6).
Differences in the three different diagnostic steps
Histological patterns alone agreed with the final diagnosis
in 67% of the cases. In 82% histology and clinical informa-
tion could provide correct clinical diagnosis compared
with final case evaluation. This provides a significant im-
provement of correct diagnosis, but only interdisciplinary
case evaluation clarified all cases adequately. Strong dis-
tinctions are found in the different diseases.
Diagnosis of IPF/UIP based on the histological pattern
alone was withdrawn in 2 cases after receiving clinical in-
formation and in further 2 cases after interdisciplinary
case evaluation. UIP pattern is compatible with the clinical
diagnosis of IPF if other etiological factors can be
excluded. A questionnaire of 11 centres for pulmonary fi-
brosis published in Germany 2003, involving 62 patients
revealed that IPF had been diagnosed usually 21 months
after the beginning of symptoms [40]. Open lung biopsies
were taken in 34%, high resolution CT was done in 71%
and precipitins were analysed only in 33%. These data
point to a relatively poor standard in the diagnosis of IPF
and excluding interstitial pneumonias of known origin
and association with UIP pattern before the publication of
the ATS/ERS statement. Limitations of the clinical criteria
for diagnosis of IPF have been demonstrated in other stud-
ies [41]. In HRCT honeycombing was seen in 44.4% of our
cases with IPF. According to the actual guideline for IPFTable 5 Distribution of the 4 main subgroups of IIP in
published cohorts
Author, Country n IPF/UIP NSIP DIP/RBILD COP
Our study, Germany 60 45% 23% 15% 17%
Bjoraker 1998, USA [18] 91 69.2% 15.4% 11% 4.4%
Nagai 1998, Japan [19] 111 58% 28% n.a. 14%
Travis 2000, USA [20] 101 55% 29% 16% n.a.
Nicholson 2000, UK [21] 78 47% 36% 17% n.a.
n.a. = not available.OLB is no longer necessary in cases with proven IPF in
the appropriate clinical and radiological setting (HRCT
with UIP pattern). Therefore OLB will now only be done
in cases with possible IPF by history and HRCT [8].
RBILD was overdiagnosed by histology plus clinical in-
formation compared with final evaluation (10 vs. 6 cases).
A variable amount of RB can be found in smokers, which
might explain overdiagnosis in those cases. Also in smo-
kers with Langerhans cell histiocytosis RB is usually seen.
Idiopathic NSIP was overdiagnosed by histology plus
clinical information compared with final evaluation (20
vs. 16 cases). Diagnosis of non-specific changes is diffi-
cult, therefore further evaluation is particularly crucial.
COP was nearly correctly diagnosed by histology plus
clinical information compared with final evaluation (12
vs. 13 cases). In one case diagnosis was withdrawn in
step 2 because changes were no longer evaluated as ad-
equately expressed. The diagnosis of OP can be difficult
if changes are only seen in small parts of the tissue. In
this entity, correlation with radiomorphology (patchy
consolidation) is essential for the correct diagnosis.
Microscopical diagnosis of DIP and LIP was done with-
out problems and remained the final diagnosis in all steps.
The DAD pattern could be diagnosed histologically as
well, but proved to be associated with rheumatoid arthritis
after case evaluation.
Diagnosis of non IIP without clinical information is diffi-
cult. Only 3 of 7 cases with LCH were diagnosed by histology
alone. In clinically suspected LCH immunohistochemistry
has to be done, which achieved correct diagnosis in all
cases. In our cases HP was not suspected by histology
alone. With clinical information, histological features of
HP were recognized in 3 of 10 patients. In chronic HP a
variety of changes ranging from UIP or NSIP patterns to
OP is known [42]. In the smoking related diseases RBILD
and LCH an overlap of patterns is seen regularly, which is
reported in the literature as well [43].
Interstitial pneumonias of other known causes and asso-
ciations are characterized by morphological patterns also
seen in IIP, the only difference is the detection of a known
etiological factor [44]. Without carefully evaluated clinical
history and laboratory examinations these diseases cannot
be diagnosed.
With regards to the BAL findings, we found that dif-
ferential cytology is of additional value in the diagnostic
Table 6 Demographics and clinical symptoms in different subgroups of IIP compared with other studies
1: Demographics and clinical symptoms in IPF
Author n m : f age dyspnoe cough symptoms (years) smoker
Our study 27 4.4:1 59.4 96.3% 77.7% 1.7 66.7%
Carrington 1978, USA [23] 53 1.7:1 51 n.d. n.d. 2.5 71%
Matuso 1996, Japan [24] 30 2.5:1 60 88.6% 100% 1.1 60%
Bjoraker 1998, USA [18] 64 1:1 65 89% 71% n.d. 54%
Daniil 1999, UK [25] 15 4:1 56 100% 60% 1.5 80%
Nicholson 2000, UK [21] 37 8.3:1 57.2 n.d. n.d. 1.3 78%
2: Demographics and clinical symptoms in NSIP
Author n m : f age dyspnoe cough symptoms (years) smoker
Our study 14 3:4 49.2 92.9% 64.3% 1.7 57%
Bjoraker 1998, USA [18] 15 1.3:1 57 100% 85% n.d. 57%
Katzenstein 1994, USA [33] 64 1:1.5 46 n.d. n.d. 0.7 58%
Park 1996, Korea [34] 7 1:6 56 n.d. n.d. 0.33 14.3%
Daniil 1999, UK [25] 15 1:1.1 56 100% 60% 1.5 60%
Nicholson 2000, UK [21] 28 2.5:1 53.5 n.d. n.d. 0.9 64.3%
Cottin 1998, France [35] 12 1:1 52.5 100% 67% n.d. 50%
3: Demographics and clinical symptoms in RBILD
Author n m : f age dyspnoe cough smoker pack years
Our study 6 5:1 44.6 66.7% 50% 100% 26.6
Myers 1987, USA [26] 6 5:1 36 83.3% 83.3% 100% 39
Yousem 1989, USA [27] 18 1.25:1 36 67% 50% 100% 32
Myers 1992, USA [36] ? 1.7:1 36.1 70.8% 58.3% 100% 33.4
Moon 1999, UK [37] 10 1:1 47.1 70% 30% 90% 39.4
4: Demographics and clinical symptoms in COP
Author n m : f age dyspnoe cough smokers
Our study 10 7:3 54.8 70% 80% 70%
Nagai 1998, Japan [19] 16 1:2 56.9 n.d. n.d. 31%
Guerry-Force 1987, Canada [29] 15 3:1 56 78.5% 86% 54.5%
Costabel 1992, Germany [38] 10 7:3 55 90% 90% n.d.
Müller 1987, Canada [31] 15 11:4 56.6 78.6% 86.7% 54.5%
King 1992, USA [32] 112 1.2:1 58 49% 72% 57%
Izumi 1992, Japan [39] 34 1:1 57 47% 76% 44%
Theegarten et al. Diagnostic Pathology 2012, 7:160 Page 9 of 12
http://www.diagnosticpathology.org/content/7/1/160process. This was also shown in other studies (Table 7).
Highest degree of lymphocytosis in IIP is seen in COP.
A percentage of over 60% is suggestive for HP. Entities
like bronchiolocentric interstitial pneumonia [45], idio-
pathic bronchiolitis [46-48] or inhaled drug induced ILD
[49], have to be excluded histologically and clinically.
Further aspects in diagnosis, prognosis and therapy of IP
will be offered by systemic biology [50], surfactant ex-
pression and immunohistochemistry [51,52], and genet-
ics [53].
Open lung biopsies are only undertaken in otherwise
unclear cases. Histology may show only non characteristicfeatures. Case specific evaluation of clinical and patho-
logical data is therefore a necessity for the exact diagnosis
of IP, which was demonstrated by other studies [10,13]
and recommended by other experts [17]. Major limita-
tions of our study were the incompleteness of reviewable
HRCT data for all patients and the lack of a second path-
ologist to calculate the level of agreement.Conclusions
Diagnosis of interstitial pneumonias, a group of quite
rare diseases, requires sufficient clinical information and
Table 7 BAL cell counts in different subgroups of IIP in other studies*
Subgroup Author n lympho. macroph. neutroph. eosinoph.
UIP/IPF Our study 22** 18.0% 64% 10% 7.5%
Haslam 1980 [54] 18 3.8% 62.7% 9.8% 4.9%
Costabel 1992 [30] 22 15% 61% 19% 5%
Matuso 1996 [24] 30 19.4% 73.1% 4.7% 2.8%
Shindoh 1986 [55] 20 22.5% 67.9% 7% 2.1%
Daniil 1999 [25] 8 8.4% 76.8% 9.6% 5.8%
Nagai 1998 [19] 64 7.2% 83% 5.9% 3.3%
RBILD Our study 5** 14% 77% 6.8% 2%
Myers 1987 [26] 3 2.3% 95.7% 2% n.d.
NSIP Our study 14** 36% 45.3% 13.3% 5%
Katzenstein 1994 [33] n.d. 37.3% 47.4% 8% 5.5%
Park 1996 [34] 7 36.5% 34.4% 23.6% 4.8%
Daniil 1999 [25] 8 9.3% 79.3% 7.8% 3.2%
COP Our study 9** 40% 46% 8% 5.7%
Nagai 1996 [56] 16 44.4% 45.5% 6.4% 2.2%
Costabel 1992 [30] 10 44% 39% 10% 6%
Epler 1994 [48] 12 41% 51% 4% 3%
*mast cells are not mentioned in all studies, therefore total numbers (percentage) do not reach 100% in each study. **results were not available in all cases.
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logical patterns.
An interdisciplinary case evaluation that includes at
least one clinical expert and one pathologist with excel-
lent expertise and the follow-up data of the patients is
necessary to find correct diagnoses.
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